Ivory Raises $1 Million to Advance Digital Cognitive Health Screening Across India

Ivory, a pioneering brain health startup, has secured $1 million in a funding round co‑led by IIM‑A Ventures and Capital A. The seed extension also attracted investment from 1Crowd, Stanford Angels, and notable angel investors Dr. Sanjay Arora, Adarsh Narahari, and Juhi Bhatnagar.

Founded in October 2022 by Issac John and Rahul Krishnan, Ivory leverages neuroscience‑based digital tools for the early detection of cognitive decline. Its FDA‑registered assessments and in‑app brain training modules deliver clinical‑grade cognitive screening directly to users’ smartphones.

The fresh capital will be deployed to enhance Ivory’s AI‑driven personalization engine, expand regional distribution networks, and fund research to define robust cognitive health benchmarks tailored to Indian populations. These improvements aim to close gaps in underdiagnosis and offer preventive solutions for neurodegenerative conditions.

Ivory’s platform already partners with clinicians, psychologists, and insurers, and has been adopted by corporates such as Ather Energy, WeWork, and PUMA. Earlier this year, the startup published its first Brain Health Report and gained widespread visibility through an appearance on Shark Tank India Season 4.

This round follows a $500K investment in February 2024 led by Capital A, bringing Ivory’s total funding to $1.5 million. Backers including TDV Partners alongside 1Crowd and Stanford Angels underscore continued confidence in the company’s vision.

As Ivory scales its distribution and deepens its research collaborations, it is poised to transform cognitive healthcare in India—making early, accessible screening and personalized brain health support available to millions.